Cancer - Leukemia
Leukemia is a cancer of the blood or bone marrow and is characterized by an abnormal proliferation of blood cells, usually white blood cells. It is part of the broad group of diseases called hematological neoplasms.
Damage to the bone marrow, by way of displacing the normal bone marrow cells with higher numbers immature white blood cells, results in a lack of blood platelets, which are important in the blood clotting process. This means people with leukemia may become bruised, bleed excessively, or develop pinprick bleeds. White blood cells, which are involved in fighting pathogens, may be suppressed or dysfunctional, putting the patient at the risk of developing infections. Finally, the red blood cell deficiency leads to anemia, which may cause dyspnea. All symptoms may also be attributable to other diseases; for diagnosis, blood tests and a bone marrow biopsy are required.
There is no single known cause for all of the different types of leukemia. The different leukemias likely have different causes, and very little is certain about what causes them. Leukemia, like other cancers, result from somatic mutations in the DNA which activate oncogenes or deactivate tumor suppressor genes, and disrupt the regulation of cell death, differentiation or division. These mutations may occur spontaneously or as a result of exposure to radiation or carcinogenic substances and are likely to be influenced by genetic factors. Cohort and case-control studies have linked exposure to petrochemicals, such as benzene, and hair dyes to the development of some forms of leukemia. Viruses have also been linked to some forms of leukemia. For example, certain cases of ALL are associated with viral infections by either the human immunodeficiency virus or human T-lymphotropic virus. Fanconi anemia is also a risk factor for developing acute myelogenous leukemia.
...More at Wikipedia
Related Links:
Cancer - Leukemia
Questions recently asked by other users
Latest Cancer / Oncology News From Medical News Today.
- Bovie Medical Corporation Announces FDA 510(K) Clearance To Market SEER Tissue Resection Device
- Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
- GenVec Announces Interim Survival Data In Pivotal Trial Of TNFerade™ In Locally Advanced Pancreatic Cancer
- Relapsed Ovarian Cancer - Submitted New Drug Application To FDA For Trabectedin
- Higher Risk Of Certain Cancers Being Recorded In HIV-Positive People
- Ovarian Cancer Cells Destroyed By New Platinum-Phosphate Compounds
- Gentium Provides An Update On The Phase 3 Treatment Trial Of Defibrotide For Severe Veno-Occlusive Disease
- Lymphoma Association Launches New Short Film
- New Imaging Technique Tracks Cancer-Killing Cells Over Prolonged Period In First-Ever Stanford Case Study
- Survival Of Head And Neck Cancer Patients Is Greatly Affected By Coexisting Ailments
- Common Virus Helps Quality Of Life For Sarcoma Patients Says Cancer Expert